Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. - Wikidata - awgldk - TriplyDB

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

http://www.wikidata.org/entity/Q37384669

about

Screening for prostate cancer Screening for prostate cancer The decline in U.S. cancer mortality in people born since 1925.Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer Incidence, mortality and survival patterns of prostate cancer among residents in Singapore from 1968 to 2002 Declining death rates reflect progress against cancer.Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study Focal therapy for prostate cancer: rationale and treatment opportunities.Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression Homogeneous prostate cancer mortality in the Nordic countries over four decades.A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006 Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.Incidence variation of prostate and cervical cancer according to socioeconomic level in the Girona Health Region.Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells.Cancer incidence in the U.S. military population: comparison with rates from the SEER program Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA.New analysis reexamines the value of cancer care in the United States compared to Western Europe Screening for prostate cancer using multivariate mixed-effects models.The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.Obesity and prostate cancer: weighing the evidence.Usability evaluation of the interactive Personal Patient Profile-Prostate decision support system with African American men.Model-based patterns in prostate cancer mortality worldwide Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China Pharmacological prophylaxis of venous thromboembolism in contemporary radical retropubic prostatectomy: does concomitant pelvic lymphadenectomy matter?Association of diabetes with prostate cancer risk in the multiethnic cohort.Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States.Robotic-assisted laparoscopic prostatectomy Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial.Should prostate-specific antigen screening be offered to asymptomatic men?The implementation of screening for prostate cancer.

P2860

Q24201690-089ECFF4-35F6-46B2-B2D7-8F5C5404D3AF Q24245476-405C072D-E925-4EB0-83B9-7EC7AAE1AD50 Q28254917-4F502DB3-202E-4C7C-AB9D-B3C2EB3C1638 Q28552296-397FE582-0D88-4A97-8EB7-06849F643499 Q28755344-3070A7D9-D375-4DBE-8787-41BB618ED14D Q30979644-03F08B8C-99DD-4F1D-BA39-DE160D8223EC Q33393412-57D4953B-4718-4F79-97E9-8EA30062D8C0 Q33541029-D9A49604-7E17-4904-B273-E87067126A8F Q33630790-AFFFB627-1D42-4174-9BDD-179FA906FFC3 Q33702259-8099FBEF-9AFC-4044-95C0-583326BB6466 Q33834396-867434F4-47AC-4409-A692-8C3D6F82F371 Q34021773-A6842B1F-3450-49D4-BFF1-612D8DAD4133 Q34028361-C99A854D-8124-4294-8029-5091A23233AA Q34085053-975952B6-617A-472E-8E26-DCF9336F4270 Q34090617-66CFC081-BD86-46B1-B659-9B307FFE52B5 Q34115819-2602DA02-FD4B-44B6-9EB6-1472FEB1058A Q34294761-DA01A6BA-5046-4769-8AF6-4A237D5624C3 Q34756267-81BD864C-EF35-4580-8B2D-0C2C605F7148 Q34875230-EB156C78-4E17-4ABE-9226-5185651E886B Q34976249-25D2BDFD-BE31-4B9D-A285-7C9451D1090E Q34985615-92F76C07-EE70-4A4D-9D03-F7BF44FBDE1C Q35127006-543C3B5F-5931-4EB8-B667-A952513EE3E4 Q35621404-42D6A884-7BC2-48E0-B585-A1F0F0CBB008 Q36009869-42297575-3979-4341-B241-B16816DAC494 Q36117229-740D3520-9AA6-40A5-9CE8-6B3C8A31860F Q36199134-5F1838FF-F98F-4B8B-A1CB-CB075BAF584E Q36520484-2E1CA84F-62FD-463D-99E1-2B340B313C39 Q36685022-60A92455-BEA8-4C4D-A3AD-6C6B40A465A7 Q36806625-298F0FC8-5E6B-48E3-927D-167A374FE12E Q36924745-017702B1-F743-4EB8-8BE2-945E11ADBE4D Q37074759-9CDCDFD7-7D0F-4EC3-A8F7-1F2CB85A65E1 Q37262195-3C9022F4-283F-49C2-9130-E424A7041125 Q37306082-988C7D3B-4FF7-4DB9-8ACF-4B59443EA347 Q37307609-B1E64D05-1D7F-4C8C-B3F5-503CED44A29A Q37361333-A8E2173E-3F5E-4F69-83CE-90C145B92712 Q37424004-C1E590EE-9173-4BF2-832E-881F0705150C Q37616568-80760717-7F21-4258-A433-B9AAF92FE448 Q37621409-23B1379F-D471-444A-BA30-47D4E98AFA48 Q37774352-D81DFE86-F405-4640-B12B-F434CDA4478F Q37777325-42EB9540-DE9E-4F8B-9641-59454CFA623A

P2860

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

http://www.wikidata.org/entity/Q37384669

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@en

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@nl

type

label

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@en

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@nl

prefLabel

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@en

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@nl

P1433

Q37384669-7D1A7FB3-A504-4BE9-8760-0F3B55D5004E

P1476

Q37384669-6182F456-9EFD-4E10-8707-CAD6F398AEF9

P2093

Q37384669-025C5527-282E-4190-BB21-C7374690B7FF

Q37384669-5E115C51-6268-4B0A-924F-62D8328FF0E5

Q37384669-7D024265-1940-4FAE-90FF-B047CCAD4A6B

Q37384669-B38BF37A-1D41-4C1F-A558-BBBC874A4BA5

Q37384669-D67A8F14-E724-4C97-B62A-18072652FFD9

Q37384669-D7C0C773-0F08-4E9E-942F-EC62E35F3DF3

Q37384669-E1A5BB66-CAE0-4969-B241-A6D6EE33981E

P2860

Q37384669-0D010D08-9EAA-49BF-B9AD-D924424AE04D

Q37384669-0EB8692F-829D-4D32-8D58-EA22A1825852

Q37384669-18D3E635-9F9B-40F5-BBFA-741A7AB8AB50

Q37384669-1D4B24DD-F87D-448E-83AF-37CD8760F798

Q37384669-26FFCE2F-2646-440E-ABA0-CD122CC10FBB

Q37384669-28A68D15-39E4-43FD-9C12-2DF35A7A8CF4

Q37384669-3222599C-AEFE-442B-8FAD-E9DF8A8FD688

Q37384669-3663F51E-13A4-4A86-BA41-2759BDC78AE2

Q37384669-38CDEA34-2E82-46B9-AD93-8DE2C1B43543

Q37384669-3BF0927D-475A-4BE0-9257-4375EC4E8AC4

P304

Q37384669-6BD87A26-1BF0-43E1-ABF2-D6414F3169AC

P31

Q37384669-289D4706-DAB8-4030-B145-AC872717DD9E

P356

Q37384669-BBB565FB-3BCC-44DC-935E-E4C84EDA0522

P433

Q37384669-48335D85-8D95-49B9-B841-5C6AC49DBC36

P478

Q37384669-C4B96BD2-3760-4A13-8C90-19BD77FEC741

P50

Q37384669-4163E60F-1D86-4DA9-A8C2-66DC4B851F62

Q37384669-826ACEA5-96B0-4AFB-95EF-15521E7F43DD

Q37384669-FC0F5CFA-384E-4449-BC9D-59FD92CF48D8

Q37384669-FE0C7AB8-E302-467D-8FE5-73D7ADC32E2B

P577

Q37384669-ACFB8650-E896-4AA0-B781-12D94768B572

P5875

Q37384669-C80FA7FA-D6B5-4A43-A7B3-44C5ABA0B535

P698

Q37384669-19D81681-8633-4BEF-B643-DAAA45A084D1

P932

Q37384669-EABF64C2-930A-4B76-967A-3F1A8BCB27C4

P356

S1470-2045(08)70104-9

P1433

The Lancet Oncology

P1476

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

@en

P2093

Chris Metcalfe

http://www.w3.org/2001/XMLSchema#string

Freddie Hamdy

http://www.w3.org/2001/XMLSchema#string

J Athene Lane

http://www.w3.org/2001/XMLSchema#string

Jenny Donovan

http://www.w3.org/2001/XMLSchema#string

Peter C Albertsen

http://www.w3.org/2001/XMLSchema#string

Peter Stephens

http://www.w3.org/2001/XMLSchema#string

Rollo Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?

The international comparability of cancer mortality data. Results of an international death certificate study.

Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review.

Changing trends in prostatic cancer.

Clinical information for research; the use of general practice databases.

Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

P304

445-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(08)70104-9

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Simon M. Collin

Richard M Martin

P577

2008-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5428909

http://www.w3.org/2001/XMLSchema#string

P698

18424233

http://www.w3.org/2001/XMLSchema#string

P932

2760747

http://www.w3.org/2001/XMLSchema#string